Search research articles
Contact Us
Filters
Showing results (161-170 of 346) with videos related to
Page
of 35
Sort By:
American Journal of Hematology
|
February 13, 2021
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia
Sangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Cancer
|
January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia
Koji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
American Journal of Hematology
|
April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden
Musa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology
|
November 6, 2025
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes
Wei J Wang, Qiudan Shen, Mehrnoosh Tashakori, et al.
American Journal of Hematology
|
April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression
Elias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Cancer
|
March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemia
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
American Journal of Hematology
|
March 31, 2022
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors
Fadi G Haddad, Koji Sasaki, Ghayas C Issa, et al.
American Journal of Hematology
|
March 10, 2022
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab
Nicholas J Short, Walid Macaron, Marina Konopleva, et al.
Leukemia & Lymphoma
|
August 7, 2020
Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years
Catherine Kendall Major, Hagop Kantarjian, Koji Sasaki, et al.
Page
of 35
Search research articles
Search
Showing results (161-170 of 346) with videos related to
Sort By:
Page
of 35
American Journal of Hematology
|
February 13, 2021
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia
Sangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Cancer
|
January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia
Koji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
American Journal of Hematology
|
April 23, 2021
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden
Musa Yilmaz, Naval Daver, Gautam Borthakur, et al.
American Journal of Hematology
|
November 6, 2025
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes
Wei J Wang, Qiudan Shen, Mehrnoosh Tashakori, et al.
American Journal of Hematology
|
April 13, 2024
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression
Elias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Cancer
|
March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemia
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
American Journal of Hematology
|
March 31, 2022
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors
Fadi G Haddad, Koji Sasaki, Ghayas C Issa, et al.
American Journal of Hematology
|
March 10, 2022
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab
Nicholas J Short, Walid Macaron, Marina Konopleva, et al.
Leukemia & Lymphoma
|
August 7, 2020
Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years
Catherine Kendall Major, Hagop Kantarjian, Koji Sasaki, et al.
Page
of 35